Ubs Group Ag Genenta Science S.P.A. Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
A detailed history of Ubs Group Ag transactions in Genenta Science S.P.A. stock. As of the latest transaction made, Ubs Group Ag holds 1,862 shares of GNTA stock, worth $9,291. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,862
Previous 893
108.51%
Holding current value
$9,291
Previous $2,000
250.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding GNTA
# of Institutions
5Shares Held
248KCall Options Held
0Put Options Held
0About Genenta Science S.p.A.
- Ticker GNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,216,900
- Market Cap $90.9M
- Description
- Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated...